Fecal Incontinence: Clinical Trials

8 trials for Fecal Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 22Completed 2

Follow Fecal Incontinence: new trials by email Literature Review of Fecal Incontinence trials Research Report on Fecal Incontinence

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence
Rectoscopy, Anorectal manometry, Botulinum toxin A or physiologic serum injection - Fecal Incontinence
Phase 3CompletedUniversity Hospital, Rouen2002015-11-252026-01-22
A Study of Colesevelam in Fecal Incontinence
Colesevelam, Clonidine, Placebo - Fecal Incontinence, Bile Acid Malabsorption
Phase 3CompletedMayo Clinic882015-11-012023-06-22
Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
Loperamide, Placebo, Anal exercises with biofeedback - Fecal Incontinence
Phase 3CompletedNICHD Pelvic Floor Disorders Network3002014-02-012018-11-20
Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence
Myoblast injection, saline solution injection - Fecal Incontinence
Phase 2 / Phase 3CompletedUniversity Hospital, Rouen242012-02-012015-10-23
UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence
Percutaneous Tibial Nerve Stimulation - Faecal Incontinence, Bowel Incontinence
Phase 3CompletedQueen Mary University of London2272012-01-012015-01-28
Percutaneous Tibial Nerve Stimulation in the Treatment of Fecal Incontinence
Urgent PC neuromodulation system - Fecal Incontinence
Phase 3CompletedMaastricht University Medical Center592009-10-012015-08-26
Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence
Psyllium powder, Loperamide - Fecal Incontinence
Phase 2 / Phase 3CompletedUS Department of Veterans Affairs802008-07-012015-04-01
Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence
Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation, EMG-biofeedback alone - Fecal Incontinence
Phase 3CompletedUniversity of Giessen1582007-07-012009-02-18

Narrower conditions

Diarrhea (2)  ·  Encopresis (1)

Broader conditions

Digestive System Diseases (8)  ·  Gastrointestinal Diseases (8)  ·  Intestinal Diseases (8)  ·  Rectal Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Signs and Symptoms, Digestive (3)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Elimination Disorders (1)  ·  Mental Disorders (1)

Interventions

Loperamide (2)  ·  Biofeedback, Psychology (1)  ·  Botulinum Toxins, Type A (1)  ·  Clonidine (1)  ·  Colesevelam Hydrochloride (1)  ·  Proctoscopy (1)  ·  Psyllium (1)  ·  Saline Solution (1)

Sponsors

University Hospital, Rouen (2)  ·  Maastricht University Medical Center (1)  ·  Mayo Clinic (1)  ·  NICHD Pelvic Floor Disorders Network (1)  ·  Queen Mary University of London (1)  ·  US Department of Veterans Affairs (1)  ·  University of Giessen (1)

Countries

France (3)  ·  United States (3)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Adil Bharucha, MBBS, MD (1)  ·  Alayne D Markland, DO MSc (1)  ·  Cornelius Baeten, prof phd md (1)  ·  J E Jelovsek (1)  ·  Matthew Barber (1)  ·  Thilo Schwandner, Dr. (1)

Results publications

PMID 20551752, PMID 21968596, PMID 25565635, PMID 28703936, PMID 31320277, PMID 38128556

NIH funding

2014 (1), R01DK078924 (1), U01HD069031 (1), U10HD041261 (1), U10HD041267 (1), U10HD054214 (1), U10HD054215 (1), U10HD069006 (1), U10HD069010 (1), U10HD069013 (1), U10HD069025 (1), UL1RR024150 (1)